HFrEF Polypill in Sri Lanka RCT
A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1672 participants.
Also called NCT07569640
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 1,672 participants
- Sponsor
- Registry
-
NCT07569640
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Sri Lanka
- Registry status
- Recruiting
Technical summary
Registry record NCT07569640. Randomized; single masking; primary purpose treatment. Start 2026-08-17 (actual); primary completion 2029-04 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- HFrEF Polypill in Sri Lanka RCT
- Intervention (Other)
- Usual Care
- Intervention (Drug)
- HFrEF Polypill
- Lead sponsor
- Washington University School of Medicine
- Collaborator
- Centre for Chronic Disease Control, India
- Collaborator
- National Heart, Lung, and Blood Institute (NHLBI)
- Collaborator
- RemediumOne (Pvt) Ltd.
- Collaborator
- University of Kelaniya
- Collaborator
- The George Institute
Record details
- Record id
cardio:ct-nct07569640- Content hash
57e6b0c4076326a20760536fd3c3933526abeb89cf8af145dbea17a62fc3cf6b